Efficacy and safety of the use of probiotics in pediatric cancer patients (Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL)) Undergoing Chemotherapy: A Meta-Analysis

Ana Margarita C Pineda, Speaker at Pediatrics Conference
Pediatrician

Ana Margarita C Pineda

Philippine Children’s Medical Center, Philippines

Abstract:

Leukemia is the most common cancer in children younger than five years of age and accounts for the highest percentage of deaths with ALL as the leading cause of death among children and adolescents. Chemotherapy causes immunosuppression and the disruption of the structural integrity of the epithelial barrier causing infections to play a pivotal role in the morbidity and mortality of childhood leukemia. This study aimed to determine the efficacy and safety of probiotics in pediatric AML and ALL patients undergoing chemotherapy in decreasing chemotherapy induced gastrointestinal side effects. A literature search for studies published from 2000 - 2021 was done and RevMan software was used to analyze the data extracted from selected studies. Outcome estimation was done using Odds Ratio (OR) with 95% confidence interval (CI). The heterogeneity in various studies was determined using the I2 test. Three studies were included in the qualitative analysis while two studies were analyzed quantitatively.

 

The major finding in our study is that the use of probiotics is significant in decreasing gastrointestinal side effects namely abdominal distention, constipation, dyspepsia, meteorism, nausea, and vomiting but that diarrhea has the same risk in both the probiotic and control group (95% CI 0.16 to 2.29). This study has found that the use of probiotics supplementation as adjunct to standard chemotherapy in pediatric patients with Acute Leukemia can reduce the risk of gastrointestinal side effects, namely abdominal distention (95% CI 0.01 to 0.76), constipation (95% CI 0.02 to 0.50), dyspepsia (95% CI 0.12 to 0.74), meteorism (95% CI 0.06 to 0.46), nausea (95% CI 0.09 to 0.76) and vomiting (95% CI 0.03 to 0.77); and may also reduce the occurrence of diarrhea. However, further assessment of more and larger-scale studies is recommended.

Biography:

Dr. Pineda is a general pediatrician who completed her pediatric training at the Philippine Children’s Medical Center. Since then, she continues to work in the public sector, providing essential health services to children and their families. Her work reflects deep commitment to improving pediatric health outcomes, advancing equitable access to care, and advocating for the well-being of her patients and the community.

Copyright 2024 Mathews International LLC All Rights Reserved

Watsapp
Top